H.R. 6238: NIH IMPROVE Act

The NIH IMPROVE Act (H.R. 6238) proposes the establishment of the IMPROVE Initiative within the National Institutes of Health (NIH). This initiative aims to enhance maternal health by funding research to reduce preventable maternal deaths and severe health complications during and after pregnancy. It focuses on addressing health disparities among different populations, understanding various factors affecting maternal health, and implementing community-based interventions. The bill authorizes $73.4 million annually from fiscal years 2026 through 2031 to support these efforts.

Supporters of the NIH IMPROVE Act commend its commitment to improving maternal health outcomes, particularly among communities with high rates of maternal mortality. The bill's emphasis on research and community-based interventions is seen as a proactive approach to addressing longstanding health disparities. The bipartisan sponsorship by Representatives Lauren Underwood and Brian K. Fitzpatrick is also highlighted as a positive aspect, indicating cross-party recognition of the importance of maternal health issues.

Critics of the NIH IMPROVE Act express concerns about the allocation of $73.4 million annually, questioning whether the funds will be effectively utilized to achieve the desired outcomes. Some argue that the bill may not sufficiently address systemic issues contributing to maternal health disparities, such as access to quality healthcare and socioeconomic factors. Additionally, there is skepticism about the potential for bureaucratic inefficiencies within the NIH to hinder the initiative's success.

The NIH IMPROVE Act, sponsored by Lauren Underwood, has significant financial backing from the health professionals sector, which contributed a total of $120 million. This substantial amount raises concerns about potential conflicts of interest, particularly as the bill pertains directly to health-related initiatives. The alignment of the sponsor's top donor industry with the subject matter of the bill suggests a strong financial incentive for the sponsor to advocate for policies that may benefit these donors. Voters should be aware that the health professionals' contributions could influence legislative priorities in ways that may not align with broader public health interests.

Additionally, while there are various lobbying activities associated with this bill, the undisclosed amounts from several entities indicate a lack of transparency that could further complicate the integrity of the legislative process. The presence of lobbying from organizations with potential stakes in health policy adds another layer of concern regarding the motivations behind the bill's sponsorship and its implications for public health policy. Voters should remain vigilant about how these financial ties may affect the outcomes of health legislation.

These industries are both affected by this bill and among the sponsor's top donors.

Organizations that lobbied on issues related to this bill's policy area.

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Top industries funding Lauren Underwood, ranked by total contributions.

Source: OpenSecrets.org (Center for Responsive Politics)